Cardiovascular morbidity and mortality are highly prevalent in patients with end-stage renal disease, and osteoprotegerin (OPG) may be an important link between bone loss and vascular calcification. This study...
from Most Recent Articles: BMC Nephrology http://bit.ly/2K6rDGe
via IFTTT
No comments:
Post a Comment